# Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

> **NCT00788515** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 33 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** Volinanserin (M100907)
- **DRUG:** Lormetazepam

## Key facts

- **NCT ID:** NCT00788515
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
- **Last updated:** 2009-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788515, "Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00788515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*